Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 16;3(1):15.
doi: 10.1186/2191-1991-3-15.

Health-related quality of life questionnaires in lung cancer trials: a systematic literature review

Kathrin Damm  1 , Nicole Roeske, Christian Jacob
Affiliations

Health-related quality of life questionnaires in lung cancer trials: a systematic literature review

Kathrin Damm et al. Health Econ Rev. .

Abstract

Background: Lung cancer is one of the leading causes of cancer deaths. Treatment goals are the relief of symptoms and the increase of overall survival. With the rising number of treatment alternatives, the need for comparable assessments of health-related quality of life (HRQoL) parameters grows. The aim of this paper was to identify and describe measurement instruments applied in lung cancer patients under drug therapy.

Methods: We conducted a systematic literature review at the beginning of 2011 using the electronic database Pubmed.

Results: A total of 43 studies were included in the review. About 17 different measurement instruments were identified, including 5 generic, 5 cancer-specific, 4 lung cancer-specific and 3 symptom-specific questionnaires. In 29 studies at least 2 instruments were used. In most cases these were cancer and lung cancer-specific ones. The most frequently used instruments are the EORTC QLQ-C30 and its lung cancer modules LC13 or LC17. Only 5 studies combined (lung) cancer-specific questionnaires with generic instruments.

Conclusions: The EORTC-C30 and EORTC-LC13 are the most frequently used health-related quality of life measurement instruments in pharmacological lung cancer trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of study selection.
Figure 2
Figure 2
Frequency of used HRQoL-questionnaires.
See this image and copyright information in PMC

References

    1. Robert Koch Institut. Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V: Krebs in Deutschland 2005/2006. Berlin: Häufigkeiten und Trends; 2010.
    1. Reck M. Quality of life as an endpoint of clinical trials. Lung Cancer. 2009;3(Suppl 1):22–23. - PubMed
    1. Liu J, Mittendorf T, von der Schulenburg JM. A structured review and guide through studies on health-related quality of life in kidney cancer, hepatocellular carcinoma, and leukemia. Cancer Invest. 2010;3:312–322. doi: 10.3109/07357900903287022. - DOI - PubMed
    1. Camps C, del Pozo N, Blasco A, Blasco P, Sirera R. Importance of quality of life in patients with Non-small-cell lung cancer. Clin Lung Cancer. 2009;3:83–90. doi: 10.3816/CLC.2009.n.010. - DOI - PubMed
    1. Schöffski O. In: Gesundheitsökonomische Evaluationen. Schöffski O, Von der Schulenburg JM, editor. Berlin: Heidelberg: Springer; 2007. Lebensqualität als Ergebnisparameter in gesundheitsökonomischen Studien; pp. 321–334.

LinkOut - more resources